Blockchain Registration Transaction Record

CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment on Promising Brain Cancer Therapy

CNS Pharmaceuticals participates in a Virtual Investor KOL Connect segment to discuss the urgent need for effective treatments in glioblastoma multiforme and the promising therapy, Berubicin. Learn more about the innovative cancer therapies offered by CNS Pharmaceuticals.

CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment on Promising Brain Cancer Therapy

This news matters as it sheds light on the urgent need for effective treatments in glioblastoma multiforme and introduces Berubicin as a potential solution. Patients, investors, and the medical community can gain valuable insights into innovative cancer therapies for aggressive brain cancers.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xf64cf2128ee2bd150b16c88c7eb5ad45fe8e56341748e3c5431b98153415dca5
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintsilkTZjn-7647509989f9e0f8e3412f64c9a519e3